查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
肌張力障礙治療藥物的全球市場規模、份額和行業趨勢分析報告：按分銷渠道、給藥途徑、類型、區域展望和預測，2022-2028 年
市場調查報告書
商品編碼
1245707

肌張力障礙治療藥物的全球市場規模、份額和行業趨勢分析報告：按分銷渠道、給藥途徑、類型、區域展望和預測，2022-2028 年

Global Dystonia Drugs Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration, By Type (GABAergic Agents, Dopaminergic Agents, Anticonvulsants Drugs), By Regional Outlook and Forecast, 2022 - 2028
出版日期: | 出版商: KBV Research | 英文 200 Pages | 訂單完成後即時交付

價格

肌張力障礙療法的全球市場規模預計到 2028 年將達到 11 億美元，預測期內復合年增長率為 5.4%。

肌張力障礙是由基底神經節功能障礙引起的，基底神經節是負責運動協調的大腦深部區域。這些大腦區域調節運動的速度和流暢性，以避免不必要的運動。肌張力障礙患者可能表現出不自主的扭曲、重複動作或異常姿勢或位置。這包括手臂、腿、軀幹、面部和聲帶。

肌張力障礙的起源尚不清楚，但許多大腦區域和連接可能會發生改變。肌張力障礙可以是遺傳性的、獲得性的或特發性的（原因不明）。遺傳性是遺傳的疾病。獲得性肌張力障礙是由腦損傷或退化（例如，腦損傷或中風後）或接觸藥物引起的。在特發性肌張力障礙中，原因不明，並且沒有大腦的解剖學損傷或退化。

COVID-19 影響分析

COVID-19 疫情正在影響醫療保健行業的運營。由於 COVID-19，包括醫療保健各個子領域在內的多個行業已被迫暫時關閉。2020 年，由於 COVID-19 引發的經濟放緩，肌張力障礙藥物市場出現下滑。此外，COVID-19 影響了醫療保健等行業的供應鏈，進一步抑制了市場增長。然而，隨著疫情的緩解，企業和供應鏈正在恢復正常，這有望幫助市場復甦。

市場增長因素

加強藥物研發

聯邦政府支持增加處方藥需求的計劃、影響新藥供應的政策（例如對基礎研究支出的監管以及必須在臨床試驗中證明的內容）以及影響供求雙方的政策。通過研發支出（例如疫苗建議）。預計製藥行業的全球研發進展將促進肌張力障礙療法的療效及其利用，從而促進市場增長。

神經系統疾病患病率上升

根據世界衛生組織 (WHO) 的一項新研究，神經系統疾病影響著全世界多達 10 億人。神經系統疾病影響所有國家的個人，不論年齡、性別、教育水平或金錢。每年約有 680 萬人死於神經系統疾病。神經系統疾病患者、他們的家人和醫療保健專業人員很難獲得適當的護理。初級衛生保健是許多人獲得醫療保健的唯一途徑。儘管有高效且廉價的藥物可供使用，但許多神經系統疾病患者仍未得到治療。需要加強衛生系統，以便為患有神經系統疾病的人提供更好的護理。

市場製約因素

絕大多數人無法獲得所需的醫療服務

根據世界銀行和世界衛生組織的一項新研究，至少有一半的人口無法獲得基本醫療保健。每年都有更多的家庭因支付醫療費用而陷入貧困。目前，有 8 億人將至少 10% 的家庭預算用於自己、生病的孩子或其他家庭成員的健康相關費用。這些成本足以讓大約 1 億人陷入極端貧困，每天的生活費不足 1.90 美元。

按類型展望

按類型劃分，肌張力障礙治療市場分為抗驚厥藥、氨基丁酸能藥物、多巴胺能藥物等。GABAergic 藥物部分在肌張力障礙治療市場佔據主導地位，2021 年收入份額最大。這種增長歸因於它在治療肌張力障礙，尤其是頸部肌張力障礙方面的益處。此外，用於治療肌張力障礙的有效且有效的 GABAergic 藥物的發現以及醫療保健專業人員更全面的處方將在預測期內推動該細分市場的擴張。

給藥途徑透視

根據給藥途徑，肌張力障礙治療市場分為口服和注射劑。2021 年，注射劑部分在肌張力障礙治療市場中佔據了重要的收入份額。這得益於腸外給藥的技術革新和肉毒桿菌注射劑的積極研發。藥物，尤其是水溶液的吸收迅速而均勻。起效比口服或皮下給藥快。肌內註射繞過藥物的首過代謝。

分銷渠道展望

按分銷渠道，肌張力障礙治療市場分為醫院藥房、在線供應商、藥店和零售藥店。2021 年，藥店和零售藥房部門在肌張力障礙治療市場的收入份額最大。這是由於其廣泛的分銷鏈，並且是向消費者提供藥品的最古老和最方便的渠道。零售藥劑師準備和分發藥物，建議消費者正確使用藥物，並告知他們潛在的藥物相互作用。我們還提供非處方藥和一般健康建議。

區域展望

按地區劃分，對北美、歐洲、亞太地區和 LAMEA 的肌張力障礙治療市場進行了分析。到 2021 年，北美將在肌張力障礙治療市場中佔據最高的收入份額。這是由於肌張力障礙的發病率增加以及導致人群肌張力障礙的其他神經系統疾病的患病率上升。該地區還擁有發達的醫療保健基礎設施、高購買力以及肌張力障礙診斷和治療的增加。高未滿足的醫療保健需求和有利的監管環境的存在預計將推動市場擴張。

目錄

第一章市場範圍與研究方法

  • 市場定義
  • 目的
  • 市場範圍
  • 分割
    • 按分銷渠道分列的肌張力障礙療法的全球市場
    • 肌張力障礙藥物的全球市場，按給藥途徑
    • 肌張力障礙治療的全球市場，按類型
    • 全球肌張力障礙治療市場，按地區
  • 調查方法

第二章市場概況

  • 是介紹
    • 概述
      • 市場構成和情景
  • 影響市場的關鍵因素
    • 市場驅動力
    • 市場製約因素

3 Dystonia 治療的全球市場，按分銷渠道

  • 全球藥店和零售藥店市場，按地區
  • 全球醫院藥房市場，按地區
  • 按地區分列的全球在線提供商市場

4 全球肌張力障礙治療市場，按給藥途徑

  • 按地區分列的全球口服藥物市場
  • 全球可注射藥物市場：按地區分類

5 全球肌張力障礙治療市場，按類型

  • 全球 GABA 能藥物市場，按地區劃分
  • 全球多巴胺能藥物市場，按地區劃分
  • 全球抗驚厥藥市場：按地區
  • 全球其他地區市場

6. 肌張力障礙療法的全球市場，按地區劃分

  • 北美
    • 北美各國肌張力障礙藥物市場趨勢
      • 美國
      • 加拿大
      • 墨西哥
      • 其他北美
  • 歐洲
    • 歐洲肌張力障礙藥物市場：按國家分類
      • 德國
      • 英國
      • 法國
      • 俄羅斯
      • 西班牙
      • 意大利
      • 歐洲其他地區
  • 亞太地區
    • 亞太地區肌張力障礙治療市場：國家名單
      • 中國
      • 日本
      • 印度
      • 韓國
      • 新加坡
      • 馬來西亞
      • 亞太其他地區
  • 拉美亞
    • 按國家分列的 LAMEA 肌張力障礙藥物市場
      • 巴西
      • 阿根廷
      • 阿聯酋
      • 沙特阿拉伯
      • 南非
      • 尼日利亞
      • 其餘的 LAMEA

第七章公司簡介

  • Pfizer, Inc.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • AbbVie, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Ipsen Pharma Biotech SAS
  • Hameln Pharma Gmbh（Siegfried Group, LLP）
  • Amneal Pharmaceuticals, Inc.
  • Merz Pharma GmbH & Co. KGaA
  • Wellona Pharma

The Global Dystonia Drugs Market size is expected to reach $1.1 billion by 2028, rising at a market growth of 5.4% CAGR during the forecast period.

Dystonia is a movement disease characterized by involuntary muscle contractions that lead to repetitive sluggish motions or aberrant postures. This muscle contraction results in aberrant muscle motions and body positions. Various types of dystonia can affect a single muscle, a group of muscles, or all of the body's muscles. It is caused by illnesses such as brain injury at or around birth, certain infections, brain trauma, and other vascular abnormalities, including stroke, arteriovenous, and others.

Patients may experience unpleasant movements or tremors as a result. There is no specific treatment for dystonia. However, its symptoms can be alleviated with various drugs. Uncontrollable muscular contractions characterize the neurological movement disorder dystonia. It is a condition that has no age, ethnic, or racial borders; it can afflict children and people of all races and ethnicities from infancy to old age.

Dystonia is caused by faulty basal ganglia functioning, a deep brain region that controls movement coordination. These brain regions regulate the speed and fluidity of movement and avoid undesired motions. Dystonic patients may exhibit involuntary twisting, repeated motions, or aberrant postures and positions. This includes the arms, legs, trunk, face, and vocal cords.

The origin of dystonia is unknown, but it may entail alterations in many brain regions or their connectivity. Dystonia may be genetic, acquired, or idiopathic in origin (no known cause). Inherited illnesses are genetically transmitted. In acquired forms, dystonia is caused by brain damage or degeneration (e.g., following a brain injury or stroke) or drug exposure. There is no known cause and no anatomical injury or degeneration of the brain in idiopathic dystonia.

COVID-19 Impact Analysis

The outbreak of COVID-19 has affected operations in the healthcare sector. Several industries, including various sub-domains of health care, have been forced to close temporarily due to COVID-19. In 2020, the market for dystonia drugs declined due to the economic slowdown triggered by COVID-19. Furthermore, COVID-19 impacted the supply chain in businesses such as healthcare, further restricting the market growth. However, with ease in the pandemic, businesses and supply chains are returning to normal, which is expected to aid the market in recovery.

Market Growth Factors

Enhancement of pharmaceutical research and development

The federal government influences private spending on research and development through programs that increase the demand for prescription drugs, through policies (like spending for basic research and regulations on what must be demonstrated in clinical trials) that affect the supply of new medicines, and through policies (like vaccine recommendations) that affect both supply and demand. The growing R&D in the pharmaceutical industry globally is expected to enhance the effectiveness of dystonia drugs and their utilization, thereby boosting the market growth.

Rise in the prevalence of neurological illnesses

According to new research from the World Health Organization (WHO), neurological illnesses impact up to one billion people globally. Neurological diseases impact individuals in all nations, regardless of age, gender, level of education, or money. Around 6.8 million people die annually due to neurological illnesses. Access to adequate care is challenging for many individuals with neurological illnesses, their families, and care providers. Primary health care is the only access to medical care for many individuals. Despite the availability of highly effective, inexpensive medications, many people with neurological disorders remain untreated. Health systems must be fortified to provide better treatment for individuals with neurological illnesses.

Market Restraining Factors

Vast amount of the population unable to receive necessary medical care.

According to new research from the World Bank and the World Health Organization, at least half of the population lacks access to crucial health care. And each year, many households are forced into poverty because they must pay for their health care. Nowadays, 800 million people spend at least 10 percent of their household budgets on health-related expenses for themselves, a sick kid, or another family member. These costs are sufficient to force about 100 million people into extreme poverty, requiring them to live on $1.90 or less per day.

Type Outlook

Based on type, the dystonia drugs market is segmented into anticonvulsants drugs, GABAergic agents, dopaminergic agents and others. The GABAergic agents segment dominated the dystonia drugs market with maximum revenue share in 2021. The growth is attributed to its benefits in treating dystonia, particularly cervical dystonia. In addition, the discovery of highly effective and potent GABAergic agent pharmaceuticals for treating dystonia, combined with its more comprehensive prescription by healthcare experts, is fueling the segment's expansion in the forecasted period.

Route of Administration Outlook

On the basis of route of administration, the dystonia drugs market is divided into oral and injectable. The injectable segment procured a substantial revenue share in the dystonia drugs market in 2021. This is because of the rise in innovations in parenteral dosing and increased research and development for botulinum injections. Absorption of the medication, especially aqueous solutions, is rapid and uniform. There is a rapid commencement of effect compared to the oral and subcutaneous methods. Injection intramuscularly bypasses the drug's first-pass metabolism.

Distribution Channel Outlook

By distribution channel, the dystonia drugs market is classified into hospital pharmacies, online providers and drug stores & retail pharmacies. The drug stores & retail pharmacies segment witnessed the largest revenue share in the dystonia drugs market in 2021. This is due to its extensive chain of distribution networks and it being the oldest and most convenient channel for providing drugs to consumers. Retail pharmacists prepare and dispense drugs, counsel consumers on the proper use of medications, and inform them of potential drug interactions. Also, retail pharmacists advise clients regarding over-the-counter medications and general health concerns.

Regional Outlook

Region-wise, the dystonia drugs market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region generated the highest revenue share in the dystonia drugs market in 2021. This is because of the growing occurrences of dystonia and the rise in the prevalence of other neurological disorders that cause dystonia in the population. In addition, the presence of a well-established healthcare infrastructure, a high purchasing power, and an increase in the diagnosis and treatment of dystonia in the region. The presence of a large number of unmet healthcare demands and a favorable regulatory environment are projected to boost the market's expansion.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Pfizer, Inc., Novartis AG, Teva Pharmaceuticals Industries Ltd., AbbVie, Inc., F. Hoffmann-La Roche Ltd., Ipsen Pharma Biotech SAS, Hameln Pharma Gmbh (Siegfried Group, LLP), Amneal Pharmaceuticals, Inc., Merz Pharma GmbH & Co. KGaA, and Wellona Pharma.

Scope of the Study

Market Segments covered in the Report:

By Distribution Channel

  • Drug Stores & Retail Pharmacies
  • Hospital Pharmacies
  • Online Providers

By Route of Administration

  • Oral
  • Injectable

By Type

  • GABAergic Agents
  • Dopaminergic Agents
  • Anticonvulsants Drugs
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Pfizer, Inc.
  • Novartis AG
  • Teva Pharmaceuticals Industries Ltd.
  • AbbVie, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Ipsen Pharma Biotech SAS
  • Hameln Pharma Gmbh (Siegfried Group, LLP)
  • Amneal Pharmaceuticals, Inc.
  • Merz Pharma GmbH & Co. KGaA
  • Wellona Pharma

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Dystonia Drugs Market, by Distribution Channel
    • 1.4.2 Global Dystonia Drugs Market, by Route of Administration
    • 1.4.3 Global Dystonia Drugs Market, by Type
    • 1.4.4 Global Dystonia Drugs Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market composition & scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Global Dystonia Drugs Market by Distribution Channel

  • 3.1 Global Drug Stores & Retail Pharmacies Market by Region
  • 3.2 Global Hospital Pharmacies Market by Region
  • 3.3 Global Online Providers Market by Region

Chapter 4. Global Dystonia Drugs Market by Route of Administration

  • 4.1 Global Oral Market by Region
  • 4.2 Global Injectable Market by Region

Chapter 5. Global Dystonia Drugs Market by Type

  • 5.1 Global GABAergic Agents Market by Region
  • 5.2 Global Dopaminergic Agents Market by Region
  • 5.3 Global Anticonvulsants Drugs Market by Region
  • 5.4 Global Others Market by Region

Chapter 6. Global Dystonia Drugs Market by Region

  • 6.1 North America Dystonia Drugs Market
    • 6.1.1 North America Dystonia Drugs Market by Distribution Channel
      • 6.1.1.1 North America Drug Stores & Retail Pharmacies Market by Country
      • 6.1.1.2 North America Hospital Pharmacies Market by Country
      • 6.1.1.3 North America Online Providers Market by Country
    • 6.1.2 North America Dystonia Drugs Market by Route of Administration
      • 6.1.2.1 North America Oral Market by Country
      • 6.1.2.2 North America Injectable Market by Country
    • 6.1.3 North America Dystonia Drugs Market by Type
      • 6.1.3.1 North America GABAergic Agents Market by Country
      • 6.1.3.2 North America Dopaminergic Agents Market by Country
      • 6.1.3.3 North America Anticonvulsants Drugs Market by Country
      • 6.1.3.4 North America Others Market by Country
    • 6.1.4 North America Dystonia Drugs Market by Country
      • 6.1.4.1 US Dystonia Drugs Market
        • 6.1.4.1.1 US Dystonia Drugs Market by Distribution Channel
        • 6.1.4.1.2 US Dystonia Drugs Market by Route of Administration
        • 6.1.4.1.3 US Dystonia Drugs Market by Type
      • 6.1.4.2 Canada Dystonia Drugs Market
        • 6.1.4.2.1 Canada Dystonia Drugs Market by Distribution Channel
        • 6.1.4.2.2 Canada Dystonia Drugs Market by Route of Administration
        • 6.1.4.2.3 Canada Dystonia Drugs Market by Type
      • 6.1.4.3 Mexico Dystonia Drugs Market
        • 6.1.4.3.1 Mexico Dystonia Drugs Market by Distribution Channel
        • 6.1.4.3.2 Mexico Dystonia Drugs Market by Route of Administration
        • 6.1.4.3.3 Mexico Dystonia Drugs Market by Type
      • 6.1.4.4 Rest of North America Dystonia Drugs Market
        • 6.1.4.4.1 Rest of North America Dystonia Drugs Market by Distribution Channel
        • 6.1.4.4.2 Rest of North America Dystonia Drugs Market by Route of Administration
        • 6.1.4.4.3 Rest of North America Dystonia Drugs Market by Type
  • 6.2 Europe Dystonia Drugs Market
    • 6.2.1 Europe Dystonia Drugs Market by Distribution Channel
      • 6.2.1.1 Europe Drug Stores & Retail Pharmacies Market by Country
      • 6.2.1.2 Europe Hospital Pharmacies Market by Country
      • 6.2.1.3 Europe Online Providers Market by Country
    • 6.2.2 Europe Dystonia Drugs Market by Route of Administration
      • 6.2.2.1 Europe Oral Market by Country
      • 6.2.2.2 Europe Injectable Market by Country
    • 6.2.3 Europe Dystonia Drugs Market by Type
      • 6.2.3.1 Europe GABAergic Agents Market by Country
      • 6.2.3.2 Europe Dopaminergic Agents Market by Country
      • 6.2.3.3 Europe Anticonvulsants Drugs Market by Country
      • 6.2.3.4 Europe Others Market by Country
    • 6.2.4 Europe Dystonia Drugs Market by Country
      • 6.2.4.1 Germany Dystonia Drugs Market
        • 6.2.4.1.1 Germany Dystonia Drugs Market by Distribution Channel
        • 6.2.4.1.2 Germany Dystonia Drugs Market by Route of Administration
        • 6.2.4.1.3 Germany Dystonia Drugs Market by Type
      • 6.2.4.2 UK Dystonia Drugs Market
        • 6.2.4.2.1 UK Dystonia Drugs Market by Distribution Channel
        • 6.2.4.2.2 UK Dystonia Drugs Market by Route of Administration
        • 6.2.4.2.3 UK Dystonia Drugs Market by Type
      • 6.2.4.3 France Dystonia Drugs Market
        • 6.2.4.3.1 France Dystonia Drugs Market by Distribution Channel
        • 6.2.4.3.2 France Dystonia Drugs Market by Route of Administration
        • 6.2.4.3.3 France Dystonia Drugs Market by Type
      • 6.2.4.4 Russia Dystonia Drugs Market
        • 6.2.4.4.1 Russia Dystonia Drugs Market by Distribution Channel
        • 6.2.4.4.2 Russia Dystonia Drugs Market by Route of Administration
        • 6.2.4.4.3 Russia Dystonia Drugs Market by Type
      • 6.2.4.5 Spain Dystonia Drugs Market
        • 6.2.4.5.1 Spain Dystonia Drugs Market by Distribution Channel
        • 6.2.4.5.2 Spain Dystonia Drugs Market by Route of Administration
        • 6.2.4.5.3 Spain Dystonia Drugs Market by Type
      • 6.2.4.6 Italy Dystonia Drugs Market
        • 6.2.4.6.1 Italy Dystonia Drugs Market by Distribution Channel
        • 6.2.4.6.2 Italy Dystonia Drugs Market by Route of Administration
        • 6.2.4.6.3 Italy Dystonia Drugs Market by Type
      • 6.2.4.7 Rest of Europe Dystonia Drugs Market
        • 6.2.4.7.1 Rest of Europe Dystonia Drugs Market by Distribution Channel
        • 6.2.4.7.2 Rest of Europe Dystonia Drugs Market by Route of Administration
        • 6.2.4.7.3 Rest of Europe Dystonia Drugs Market by Type
  • 6.3 Asia Pacific Dystonia Drugs Market
    • 6.3.1 Asia Pacific Dystonia Drugs Market by Distribution Channel
      • 6.3.1.1 Asia Pacific Drug Stores & Retail Pharmacies Market by Country
      • 6.3.1.2 Asia Pacific Hospital Pharmacies Market by Country
      • 6.3.1.3 Asia Pacific Online Providers Market by Country
    • 6.3.2 Asia Pacific Dystonia Drugs Market by Route of Administration
      • 6.3.2.1 Asia Pacific Oral Market by Country
      • 6.3.2.2 Asia Pacific Injectable Market by Country
    • 6.3.3 Asia Pacific Dystonia Drugs Market by Type
      • 6.3.3.1 Asia Pacific GABAergic Agents Market by Country
      • 6.3.3.2 Asia Pacific Dopaminergic Agents Market by Country
      • 6.3.3.3 Asia Pacific Anticonvulsants Drugs Market by Country
      • 6.3.3.4 Asia Pacific Others Market by Country
    • 6.3.4 Asia Pacific Dystonia Drugs Market by Country
      • 6.3.4.1 China Dystonia Drugs Market
        • 6.3.4.1.1 China Dystonia Drugs Market by Distribution Channel
        • 6.3.4.1.2 China Dystonia Drugs Market by Route of Administration
        • 6.3.4.1.3 China Dystonia Drugs Market by Type
      • 6.3.4.2 Japan Dystonia Drugs Market
        • 6.3.4.2.1 Japan Dystonia Drugs Market by Distribution Channel
        • 6.3.4.2.2 Japan Dystonia Drugs Market by Route of Administration
        • 6.3.4.2.3 Japan Dystonia Drugs Market by Type
      • 6.3.4.3 India Dystonia Drugs Market
        • 6.3.4.3.1 India Dystonia Drugs Market by Distribution Channel
        • 6.3.4.3.2 India Dystonia Drugs Market by Route of Administration
        • 6.3.4.3.3 India Dystonia Drugs Market by Type
      • 6.3.4.4 South Korea Dystonia Drugs Market
        • 6.3.4.4.1 South Korea Dystonia Drugs Market by Distribution Channel
        • 6.3.4.4.2 South Korea Dystonia Drugs Market by Route of Administration
        • 6.3.4.4.3 South Korea Dystonia Drugs Market by Type
      • 6.3.4.5 Singapore Dystonia Drugs Market
        • 6.3.4.5.1 Singapore Dystonia Drugs Market by Distribution Channel
        • 6.3.4.5.2 Singapore Dystonia Drugs Market by Route of Administration
        • 6.3.4.5.3 Singapore Dystonia Drugs Market by Type
      • 6.3.4.6 Malaysia Dystonia Drugs Market
        • 6.3.4.6.1 Malaysia Dystonia Drugs Market by Distribution Channel
        • 6.3.4.6.2 Malaysia Dystonia Drugs Market by Route of Administration
        • 6.3.4.6.3 Malaysia Dystonia Drugs Market by Type
      • 6.3.4.7 Rest of Asia Pacific Dystonia Drugs Market
        • 6.3.4.7.1 Rest of Asia Pacific Dystonia Drugs Market by Distribution Channel
        • 6.3.4.7.2 Rest of Asia Pacific Dystonia Drugs Market by Route of Administration
        • 6.3.4.7.3 Rest of Asia Pacific Dystonia Drugs Market by Type
  • 6.4 LAMEA Dystonia Drugs Market
    • 6.4.1 LAMEA Dystonia Drugs Market by Distribution Channel
      • 6.4.1.1 LAMEA Drug Stores & Retail Pharmacies Market by Country
      • 6.4.1.2 LAMEA Hospital Pharmacies Market by Country
      • 6.4.1.3 LAMEA Online Providers Market by Country
    • 6.4.2 LAMEA Dystonia Drugs Market by Route of Administration
      • 6.4.2.1 LAMEA Oral Market by Country
      • 6.4.2.2 LAMEA Injectable Market by Country
    • 6.4.3 LAMEA Dystonia Drugs Market by Type
      • 6.4.3.1 LAMEA GABAergic Agents Market by Country
      • 6.4.3.2 LAMEA Dopaminergic Agents Market by Country
      • 6.4.3.3 LAMEA Anticonvulsants Drugs Market by Country
      • 6.4.3.4 LAMEA Others Market by Country
    • 6.4.4 LAMEA Dystonia Drugs Market by Country
      • 6.4.4.1 Brazil Dystonia Drugs Market
        • 6.4.4.1.1 Brazil Dystonia Drugs Market by Distribution Channel
        • 6.4.4.1.2 Brazil Dystonia Drugs Market by Route of Administration
        • 6.4.4.1.3 Brazil Dystonia Drugs Market by Type
      • 6.4.4.2 Argentina Dystonia Drugs Market
        • 6.4.4.2.1 Argentina Dystonia Drugs Market by Distribution Channel
        • 6.4.4.2.2 Argentina Dystonia Drugs Market by Route of Administration
        • 6.4.4.2.3 Argentina Dystonia Drugs Market by Type
      • 6.4.4.3 UAE Dystonia Drugs Market
        • 6.4.4.3.1 UAE Dystonia Drugs Market by Distribution Channel
        • 6.4.4.3.2 UAE Dystonia Drugs Market by Route of Administration
        • 6.4.4.3.3 UAE Dystonia Drugs Market by Type
      • 6.4.4.4 Saudi Arabia Dystonia Drugs Market
        • 6.4.4.4.1 Saudi Arabia Dystonia Drugs Market by Distribution Channel
        • 6.4.4.4.2 Saudi Arabia Dystonia Drugs Market by Route of Administration
        • 6.4.4.4.3 Saudi Arabia Dystonia Drugs Market by Type
      • 6.4.4.5 South Africa Dystonia Drugs Market
        • 6.4.4.5.1 South Africa Dystonia Drugs Market by Distribution Channel
        • 6.4.4.5.2 South Africa Dystonia Drugs Market by Route of Administration
        • 6.4.4.5.3 South Africa Dystonia Drugs Market by Type
      • 6.4.4.6 Nigeria Dystonia Drugs Market
        • 6.4.4.6.1 Nigeria Dystonia Drugs Market by Distribution Channel
        • 6.4.4.6.2 Nigeria Dystonia Drugs Market by Route of Administration
        • 6.4.4.6.3 Nigeria Dystonia Drugs Market by Type
      • 6.4.4.7 Rest of LAMEA Dystonia Drugs Market
        • 6.4.4.7.1 Rest of LAMEA Dystonia Drugs Market by Distribution Channel
        • 6.4.4.7.2 Rest of LAMEA Dystonia Drugs Market by Route of Administration
        • 6.4.4.7.3 Rest of LAMEA Dystonia Drugs Market by Type

Chapter 7. Company Profiles

  • 7.1 Pfizer, Inc.
    • 7.1.1 Company Overview
    • 7.1.2 Financial Analysis
    • 7.1.3 Regional & Segmental Analysis
    • 7.1.4 Research & Development Expense
  • 7.2 Novartis AG
    • 7.2.1 Company Overview
    • 7.2.2 Financial Analysis
    • 7.2.3 Segmental and Regional Analysis
    • 7.2.4 Research & Development Expense
  • 7.3 Teva Pharmaceutical Industries Ltd.
    • 7.3.1 Company Overview
    • 7.3.2 Financial Analysis
    • 7.3.3 Regional Analysis
    • 7.3.4 Research & Development Expenses
    • 7.3.5 Recent strategies and developments:
      • 7.3.5.1 Product Launches and Product Expansions:
  • 7.4 AbbVie, Inc.
    • 7.4.1 Company Overview
    • 7.4.2 Financial Analysis
    • 7.4.3 Regional Analysis
    • 7.4.4 Research & Development Expense
  • 7.5 F. Hoffmann-La Roche Ltd.
    • 7.5.1 Company Overview
    • 7.5.2 Financial Analysis
    • 7.5.3 Segmental and Regional Analysis
    • 7.5.4 Research & Development Expense
  • 7.6 Ipsen Pharma Biotech SAS
    • 7.6.1 Company Overview
    • 7.6.2 Financial Analysis
    • 7.6.3 Segmental and Regional Analysis
    • 7.6.4 Research & Development Expense
  • 7.7 Hameln Pharma Gmbh (Siegfried Group, LLP)
    • 7.7.1 Company Overview
    • 7.7.2 Financial Analysis
    • 7.7.3 Research & Development Expenses
  • 7.8 Amneal Pharmaceuticals, Inc.
    • 7.8.1 Company Overview
    • 7.8.2 Financial Analysis
    • 7.8.3 Segmental Analysis
    • 7.8.4 Research & Development Expenses
  • 7.9 Merz Pharma GmbH & Co. KGaA
    • 7.9.1 Company Overview
    • 7.9.2 Recent strategies and developments:
      • 7.9.2.1 Approvals and Trials:
  • 7.10. Wellona Pharma
    • 7.10.1 Company Overview

LIST OF TABLES

  • TABLE 1 Global Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 2 Global Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 3 Global Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 4 Global Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 5 Global Drug Stores & Retail Pharmacies Market by Region, 2018 - 2021, USD Million
  • TABLE 6 Global Drug Stores & Retail Pharmacies Market by Region, 2022 - 2028, USD Million
  • TABLE 7 Global Hospital Pharmacies Market by Region, 2018 - 2021, USD Million
  • TABLE 8 Global Hospital Pharmacies Market by Region, 2022 - 2028, USD Million
  • TABLE 9 Global Online Providers Market by Region, 2018 - 2021, USD Million
  • TABLE 10 Global Online Providers Market by Region, 2022 - 2028, USD Million
  • TABLE 11 Global Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 12 Global Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 13 Global Oral Market by Region, 2018 - 2021, USD Million
  • TABLE 14 Global Oral Market by Region, 2022 - 2028, USD Million
  • TABLE 15 Global Injectable Market by Region, 2018 - 2021, USD Million
  • TABLE 16 Global Injectable Market by Region, 2022 - 2028, USD Million
  • TABLE 17 Global Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 18 Global Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 19 Global GABAergic Agents Market by Region, 2018 - 2021, USD Million
  • TABLE 20 Global GABAergic Agents Market by Region, 2022 - 2028, USD Million
  • TABLE 21 Global Dopaminergic Agents Market by Region, 2018 - 2021, USD Million
  • TABLE 22 Global Dopaminergic Agents Market by Region, 2022 - 2028, USD Million
  • TABLE 23 Global Anticonvulsants Drugs Market by Region, 2018 - 2021, USD Million
  • TABLE 24 Global Anticonvulsants Drugs Market by Region, 2022 - 2028, USD Million
  • TABLE 25 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 26 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 27 Global Dystonia Drugs Market by Region, 2018 - 2021, USD Million
  • TABLE 28 Global Dystonia Drugs Market by Region, 2022 - 2028, USD Million
  • TABLE 29 North America Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 30 North America Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 31 North America Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 32 North America Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 33 North America Drug Stores & Retail Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 34 North America Drug Stores & Retail Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 35 North America Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 36 North America Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 37 North America Online Providers Market by Country, 2018 - 2021, USD Million
  • TABLE 38 North America Online Providers Market by Country, 2022 - 2028, USD Million
  • TABLE 39 North America Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 40 North America Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 41 North America Oral Market by Country, 2018 - 2021, USD Million
  • TABLE 42 North America Oral Market by Country, 2022 - 2028, USD Million
  • TABLE 43 North America Injectable Market by Country, 2018 - 2021, USD Million
  • TABLE 44 North America Injectable Market by Country, 2022 - 2028, USD Million
  • TABLE 45 North America Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 46 North America Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 47 North America GABAergic Agents Market by Country, 2018 - 2021, USD Million
  • TABLE 48 North America GABAergic Agents Market by Country, 2022 - 2028, USD Million
  • TABLE 49 North America Dopaminergic Agents Market by Country, 2018 - 2021, USD Million
  • TABLE 50 North America Dopaminergic Agents Market by Country, 2022 - 2028, USD Million
  • TABLE 51 North America Anticonvulsants Drugs Market by Country, 2018 - 2021, USD Million
  • TABLE 52 North America Anticonvulsants Drugs Market by Country, 2022 - 2028, USD Million
  • TABLE 53 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 54 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 55 North America Dystonia Drugs Market by Country, 2018 - 2021, USD Million
  • TABLE 56 North America Dystonia Drugs Market by Country, 2022 - 2028, USD Million
  • TABLE 57 US Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 58 US Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 59 US Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 60 US Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 61 US Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 62 US Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 63 US Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 64 US Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 65 Canada Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 66 Canada Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 67 Canada Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 68 Canada Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 69 Canada Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 70 Canada Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 71 Canada Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 72 Canada Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 73 Mexico Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 74 Mexico Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 75 Mexico Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 76 Mexico Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 77 Mexico Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 78 Mexico Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 79 Mexico Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 80 Mexico Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 81 Rest of North America Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 82 Rest of North America Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 83 Rest of North America Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 84 Rest of North America Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 85 Rest of North America Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 86 Rest of North America Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 87 Rest of North America Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 88 Rest of North America Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 89 Europe Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 90 Europe Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 91 Europe Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 92 Europe Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 93 Europe Drug Stores & Retail Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 94 Europe Drug Stores & Retail Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 95 Europe Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 96 Europe Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 97 Europe Online Providers Market by Country, 2018 - 2021, USD Million
  • TABLE 98 Europe Online Providers Market by Country, 2022 - 2028, USD Million
  • TABLE 99 Europe Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 100 Europe Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 101 Europe Oral Market by Country, 2018 - 2021, USD Million
  • TABLE 102 Europe Oral Market by Country, 2022 - 2028, USD Million
  • TABLE 103 Europe Injectable Market by Country, 2018 - 2021, USD Million
  • TABLE 104 Europe Injectable Market by Country, 2022 - 2028, USD Million
  • TABLE 105 Europe Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 106 Europe Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 107 Europe GABAergic Agents Market by Country, 2018 - 2021, USD Million
  • TABLE 108 Europe GABAergic Agents Market by Country, 2022 - 2028, USD Million
  • TABLE 109 Europe Dopaminergic Agents Market by Country, 2018 - 2021, USD Million
  • TABLE 110 Europe Dopaminergic Agents Market by Country, 2022 - 2028, USD Million
  • TABLE 111 Europe Anticonvulsants Drugs Market by Country, 2018 - 2021, USD Million
  • TABLE 112 Europe Anticonvulsants Drugs Market by Country, 2022 - 2028, USD Million
  • TABLE 113 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 114 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 115 Europe Dystonia Drugs Market by Country, 2018 - 2021, USD Million
  • TABLE 116 Europe Dystonia Drugs Market by Country, 2022 - 2028, USD Million
  • TABLE 117 Germany Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 118 Germany Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 119 Germany Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 120 Germany Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 121 Germany Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 122 Germany Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 123 Germany Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 124 Germany Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 125 UK Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 126 UK Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 127 UK Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 128 UK Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 129 UK Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 130 UK Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 131 UK Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 132 UK Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 133 France Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 134 France Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 135 France Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 136 France Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 137 France Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 138 France Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 139 France Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 140 France Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 141 Russia Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 142 Russia Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 143 Russia Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 144 Russia Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 145 Russia Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 146 Russia Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 147 Russia Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 148 Russia Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 149 Spain Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 150 Spain Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 151 Spain Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 152 Spain Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 153 Spain Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 154 Spain Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 155 Spain Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 156 Spain Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 157 Italy Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 158 Italy Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 159 Italy Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 160 Italy Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 161 Italy Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 162 Italy Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 163 Italy Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 164 Italy Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 165 Rest of Europe Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 166 Rest of Europe Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 167 Rest of Europe Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 168 Rest of Europe Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 169 Rest of Europe Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 170 Rest of Europe Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 171 Rest of Europe Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 172 Rest of Europe Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 173 Asia Pacific Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 174 Asia Pacific Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 175 Asia Pacific Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 176 Asia Pacific Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 177 Asia Pacific Drug Stores & Retail Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 178 Asia Pacific Drug Stores & Retail Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 179 Asia Pacific Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 180 Asia Pacific Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 181 Asia Pacific Online Providers Market by Country, 2018 - 2021, USD Million
  • TABLE 182 Asia Pacific Online Providers Market by Country, 2022 - 2028, USD Million
  • TABLE 183 Asia Pacific Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 184 Asia Pacific Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 185 Asia Pacific Oral Market by Country, 2018 - 2021, USD Million
  • TABLE 186 Asia Pacific Oral Market by Country, 2022 - 2028, USD Million
  • TABLE 187 Asia Pacific Injectable Market by Country, 2018 - 2021, USD Million
  • TABLE 188 Asia Pacific Injectable Market by Country, 2022 - 2028, USD Million
  • TABLE 189 Asia Pacific Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 190 Asia Pacific Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 191 Asia Pacific GABAergic Agents Market by Country, 2018 - 2021, USD Million
  • TABLE 192 Asia Pacific GABAergic Agents Market by Country, 2022 - 2028, USD Million
  • TABLE 193 Asia Pacific Dopaminergic Agents Market by Country, 2018 - 2021, USD Million
  • TABLE 194 Asia Pacific Dopaminergic Agents Market by Country, 2022 - 2028, USD Million
  • TABLE 195 Asia Pacific Anticonvulsants Drugs Market by Country, 2018 - 2021, USD Million
  • TABLE 196 Asia Pacific Anticonvulsants Drugs Market by Country, 2022 - 2028, USD Million
  • TABLE 197 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 198 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 199 Asia Pacific Dystonia Drugs Market by Country, 2018 - 2021, USD Million
  • TABLE 200 Asia Pacific Dystonia Drugs Market by Country, 2022 - 2028, USD Million
  • TABLE 201 China Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 202 China Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 203 China Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 204 China Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 205 China Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 206 China Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 207 China Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 208 China Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 209 Japan Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 210 Japan Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 211 Japan Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 212 Japan Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 213 Japan Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 214 Japan Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 215 Japan Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 216 Japan Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 217 India Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 218 India Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 219 India Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 220 India Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 221 India Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 222 India Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 223 India Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 224 India Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 225 South Korea Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 226 South Korea Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 227 South Korea Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 228 South Korea Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 229 South Korea Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 230 South Korea Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 231 South Korea Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 232 South Korea Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 233 Singapore Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 234 Singapore Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 235 Singapore Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 236 Singapore Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 237 Singapore Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 238 Singapore Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 239 Singapore Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 240 Singapore Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 241 Malaysia Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 242 Malaysia Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 243 Malaysia Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 244 Malaysia Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 245 Malaysia Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 246 Malaysia Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 247 Malaysia Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 248 Malaysia Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 249 Rest of Asia Pacific Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 250 Rest of Asia Pacific Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 251 Rest of Asia Pacific Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 252 Rest of Asia Pacific Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 253 Rest of Asia Pacific Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 254 Rest of Asia Pacific Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 255 Rest of Asia Pacific Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 256 Rest of Asia Pacific Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 257 LAMEA Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 258 LAMEA Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 259 LAMEA Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 260 LAMEA Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 261 LAMEA Drug Stores & Retail Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 262 LAMEA Drug Stores & Retail Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 263 LAMEA Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 264 LAMEA Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 265 LAMEA Online Providers Market by Country, 2018 - 2021, USD Million
  • TABLE 266 LAMEA Online Providers Market by Country, 2022 - 2028, USD Million
  • TABLE 267 LAMEA Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 268 LAMEA Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 269 LAMEA Oral Market by Country, 2018 - 2021, USD Million
  • TABLE 270 LAMEA Oral Market by Country, 2022 - 2028, USD Million
  • TABLE 271 LAMEA Injectable Market by Country, 2018 - 2021, USD Million
  • TABLE 272 LAMEA Injectable Market by Country, 2022 - 2028, USD Million
  • TABLE 273 LAMEA Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 274 LAMEA Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 275 LAMEA GABAergic Agents Market by Country, 2018 - 2021, USD Million
  • TABLE 276 LAMEA GABAergic Agents Market by Country, 2022 - 2028, USD Million
  • TABLE 277 LAMEA Dopaminergic Agents Market by Country, 2018 - 2021, USD Million
  • TABLE 278 LAMEA Dopaminergic Agents Market by Country, 2022 - 2028, USD Million
  • TABLE 279 LAMEA Anticonvulsants Drugs Market by Country, 2018 - 2021, USD Million
  • TABLE 280 LAMEA Anticonvulsants Drugs Market by Country, 2022 - 2028, USD Million
  • TABLE 281 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 282 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 283 LAMEA Dystonia Drugs Market by Country, 2018 - 2021, USD Million
  • TABLE 284 LAMEA Dystonia Drugs Market by Country, 2022 - 2028, USD Million
  • TABLE 285 Brazil Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 286 Brazil Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 287 Brazil Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 288 Brazil Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 289 Brazil Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 290 Brazil Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 291 Brazil Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 292 Brazil Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 293 Argentina Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 294 Argentina Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 295 Argentina Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 296 Argentina Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 297 Argentina Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 298 Argentina Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 299 Argentina Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 300 Argentina Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 301 UAE Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 302 UAE Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 303 UAE Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 304 UAE Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 305 UAE Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 306 UAE Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 307 UAE Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 308 UAE Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 309 Saudi Arabia Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 310 Saudi Arabia Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 311 Saudi Arabia Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 312 Saudi Arabia Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 313 Saudi Arabia Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 314 Saudi Arabia Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 315 Saudi Arabia Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 316 Saudi Arabia Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 317 South Africa Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 318 South Africa Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 319 South Africa Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 320 South Africa Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 321 South Africa Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 322 South Africa Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 323 South Africa Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 324 South Africa Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 325 Nigeria Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 326 Nigeria Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 327 Nigeria Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 328 Nigeria Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 329 Nigeria Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 330 Nigeria Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 331 Nigeria Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 332 Nigeria Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 333 Rest of LAMEA Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 334 Rest of LAMEA Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 335 Rest of LAMEA Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 336 Rest of LAMEA Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 337 Rest of LAMEA Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 338 Rest of LAMEA Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 339 Rest of LAMEA Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 340 Rest of LAMEA Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 341 Key Information - Pfizer, Inc.
  • TABLE 342 Key Information - Novartis AG
  • TABLE 343 Key Information - Teva Pharmaceuticals Industries Ltd.
  • TABLE 344 Key information - AbbVie, Inc.
  • TABLE 345 KEY INFORMATION - F. Hoffmann-La Roche Ltd.
  • TABLE 346 Key Information - Ipsen Pharma Biotech SAS
  • TABLE 347 Key Information - Hameln Pharma Gmbh
  • TABLE 348 Key Information - Amneal Pharmaceuticals, INc.
  • TABLE 349 Key information - Merz Pharma GmbH & Co. KGaA
  • TABLE 350 Key Information - Wellona Pharma

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Global Dystonia Drugs Market Share by Distribution Channel, 2021
  • FIG 3 Global Dystonia Drugs Market Share by Distribution Channel, 2028
  • FIG 4 Global Dystonia Drugs Market by Distribution Channel, 2018 - 2028, USD Million
  • FIG 5 Global Dystonia Drugs Market Share by Route of Administration, 2021
  • FIG 6 Global Dystonia Drugs Market Share by Route of Administration, 2028
  • FIG 7 Global Dystonia Drugs Market by Route of Administration, 2018 - 2028, USD Million
  • FIG 8 Global Dystonia Drugs Market Share by Type, 2021
  • FIG 9 Global Dystonia Drugs Market Share by Type, 2028
  • FIG 10 Global Dystonia Drugs Market by Type, 2018 - 2028, USD Million
  • FIG 11 Global Dystonia Drugs Market Share by Region, 2021
  • FIG 12 Global Dystonia Drugs Market Share by Region, 2028
  • FIG 13 Global Dystonia Drugs Market by Region, 2018 - 2028, USD Million